|
For Immediate Release
OurPet’s Releases Fourth Quarter and Year Results
·
Sales and Profit Improve
·
Litigation Settlement Results in
Extraordinary Gain
·
Financial Position Strengthened
·
Board Members Convert $150,000 of Debt to
Equity
·
Marketing & Sales Reorganized and
Strengthened
·
Major New Products Launch Planned
Fairport Harbor, OH – February
17, 2004: OurPet’s Company (OPCO OTCBB) today
reported financial results for its fourth quarter and year
ended December 31, 2003. Net sales for the fourth quarter
were $1,381,000, a decrease of 3% compared to $1,422,000 for
the prior year fourth quarter. Due to uncontrollable
events, over $100,000 of sales slipped into the First
Quarter of 2004. Gross profit for the quarter was $300,000
or 22% of net sales compared to $418,000 or 29% of net sales
for the prior year quarter. This decrease in gross profit
was caused by the change in product mix to an increase in
sales of items with a lower gross margin. The loss before
extraordinary item for the quarter was $204,000 compared to
income before extraordinary item of $53,000 for the same
period in 2002. This was the result of the decrease in
gross profit and the write-off of tooling and inventory
associated with discontinued products. After the
extraordinary item resulting from the litigation settlement
the net income for the quarter was $644,000 compared to net
income of $53,000 for the prior year. Earnings per share
were $0.06 vs. $.00 for the same period in 2002.
For the year net sales were $5,181,000,
an increase of 10% compared to $4,693,000 for the prior
year. Gross profit for the year was $1,249,000 or 24% of
net sales compared to $1,183,000 or 25% of net sales for the
prior year. The small decrease in percentage gross profit
when net sales increased 10% was due to the change in
product mix to items with a lower gross profit this year.
The loss before extraordinary item for the year was $408,000
compared to a loss of $270,000 in the prior year as a result
of the write-off of tooling and inventory associated with
discontinued products in the current year. After the
extraordinary item from the litigation settlement the net
income for the current year was $440,000 compared to a net
loss of $270,000 for the prior year or a $710,000
improvement. Earnings per share were $.03 vs. ($.03) for
2002.
In December, OurPet’s finalized an
agreement to settle all litigation with our former
intellectual property counsel, their attorneys, and
insurers. In exchange for full and final releases of all
claims between and among the parties, OurPet’s received
approximately $879,000 after deductions for contingent and
unpaid legal fees. After deducting other legal fees and
expenses incurred in the litigation, OurPet’s recognized an
extraordinary gain of approximately $848,000 in 2003. “We
are very pleased to put this distraction behind us since a
significant amount of financial and management resources
were diverted to this activity during the last three years”
said Dr. Tsengas.
The following table summarized
financial highlights for the Fourth Quarter and Year:
|
|
Fourth Quarter |
Year |
|
|
2003 |
2002 |
2003 |
2002 |
|
Net Sales |
$1,381,146 |
$1,422,458 |
$5,180,779 |
$4,693,222 |
|
Gross Profit |
300,237 |
417,721 |
1,248,571 |
1,183,038 |
|
Income (Loss) From
Operations |
(38,630) |
82,431 |
(122,163) |
(154,399) |
|
Income (Loss)
Before
Extraordinary Item
|
(203,942) |
52,671 |
(407,980) |
(270,258) |
|
Extraordinary Item |
848,166 |
0 |
848,166 |
0 |
|
Net Income (Loss) |
644,224 |
52,671 |
440,186 |
(270,258) |
|
Basic and Diluted
Earnings Per Share: |
|
|
|
|
|
Income (Loss)
Before Extraordinary
Item |
(0.02) |
0.00 |
(0.04) |
(0.03) |
|
Extraordinary
Item |
0.08 |
0.00 |
0.07 |
0.00 |
|
Net Income (Loss) |
0.06 |
0.00 |
0.03 |
(0.03) |
Dr. Steven Tsengas, President and CEO
stated “Although Fourth Quarter and results for the Year
were disappointing, they do provide a strong base for future
growth in sales and profits.”
Key summary points:
1.
Net income for the year of $440,186 represents an
improvement of $710,000 from 2002. Although expense for the
write-off of tooling and inventory associated with
discontinued products impacted net income, it had no impact
on the Company’s cash flow and should have a positive impact
on future earnings due to reduced depreciation, personal
property taxes, warehouse and handling costs. Working
Capital improved from $272,205 in 2002 to $977,334 or by
$705,129 providing greater resources for future growth.
2.
Due to the improved net income and conversion of
$150,000 in notes payable to equity by certain Board Members
in 2003, OurPet’s balance sheet has been strengthened from
2002:
·
Liquidity, as measured by the Current Ratio
improved to 1.7 to 1.0 from 1.1 to 1.0
·
Debt was reduced to $927,323 from $1,564,393
or by 41% which will significantly reduce our interest
expense
·
Shareholder’s equity improved by $590,186 to
$1,650,575
3.
Marketing and Sales costs and activities were
carefully reviewed and changes made to make OurPet’s more
market driven and better focused. Dr. Tsengas, working
closely with both the Vice President of Marketing and the
National Sales Manager, will play a much more active role
with customers in the future.
4.
OurPet’s plans to officially launch approximately
fifty (50) new, proprietary, innovative products at the
American Pet Product Manufacturers (APPMA) Show in March
2004. Although, some of these new products have begun
generating revenues during the First Quarter of 2004, the
major impact will be felt after the APPMA Show.
OurPet’s designs, produces and markets
in the USA and overseas a broad line of innovative,
high-quality accessory and consumable pet products.
Investors and customers may visit
www.ourpets.com for more information about the
company and its products. The APPMA * survey estimates the
U.S. market for pet products at $32 billion, with a
long-term annual growth rate of 10 percent. The APPMA
estimates an American pet population of 68 million dogs, 73
million cats and 19 million birds.
* APPMA, 2002/2003 National Pet Owners Survey
OURPET’S COMPANY AND
SUBSIDIARIES
CONSOLIDATED
OPERATING RESULTS
|
|
For the Year Ended
December 31, |
For the Quarter
Ended
December 31, |
|
|
2003 |
2002 |
2003 |
2002 |
|
|
|
|
|
|
|
Net revenue |
$5,180,779 |
$4,693,222 |
$1,381,146 |
$1,422,458 |
|
Less: Costs and
expenses
Cost of goods sold |
3,932,208 |
3,510,184 |
1,080,909 |
1,004,737 |
|
Selling, general
and administrative expenses |
1,370,734 |
1,337,437 |
338,867 |
335,290 |
|
Income (loss) from
operations |
(122,163) |
(154,399) |
(38,630) |
82,431 |
|
Other income and
expense |
(176,212) |
3,954 |
(136,158) |
891 |
|
Interest expense |
(109,605) |
(119,813) |
(29,154) |
(30,651) |
|
Income (loss) before
extraordinary item |
(407,980) |
(270,258) |
(203,942) |
52,671 |
|
Extraordinary item –
gain on litigation settlement |
848,166 |
- |
848,166 |
- |
|
Net income (loss) |
$440,186 |
$(270,258) |
$644,224 |
$52,671 |
|
|
|
|
|
|
|
Basic and diluted
earnings per common share after dividend
requirements for Preferred Stock: |
|
|
|
|
|
Income (loss)
before extraordinary item |
$(0.04) |
$(0.03) |
$(0.02) |
$- |
|
Extraordinary item |
0.07 |
- |
0.08 |
- |
|
Net income (loss) |
$0.03 |
$(0.03) |
$0.06 |
$- |
CONSOLIDATED BALANCE
SHEETS
|
|
December 31, |
|
|
2003 |
2002 |
|
|
|
|
|
ASSETS |
|
|
|
Cash and
equivalents |
$36,592 |
$36,434 |
|
Receivables, net |
629,299 |
660,214 |
|
Inventories |
1,627,000 |
1,702,847 |
|
Prepaid expenses |
147,244 |
30,006 |
|
Total current
assets |
2,440,135 |
2,429,501 |
|
Property and
equipment, net |
661,863 |
806,054 |
|
Other |
114,331 |
136,124 |
|
|
|
|
|
Total assets |
$3,216,329 |
$3,371,679 |
|
|
|
|
|
LIABILITIES AND
STOCKHOLDER’S EQUITY |
|
|
|
Short-term
borrowings and current maturities of long-term debt |
$824,370 |
$1,410,399 |
|
Accounts payable |
545,736 |
607,459 |
|
Accrued expenses |
92,695 |
139,438 |
|
Total current
liabilities |
1,462,801 |
2,157,296 |
|
Long-term debt |
102,953 |
153,994 |
|
Stockholders’
Equity |
1,650,575 |
1,060,389 |
|
|
|
|
|
Total
liabilities and stockholders’ equity |
$3,216,329 |
$3,371,679 |
This news release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements
contain the words "projects," "anticipates," "believes,"
"expects," "intends," "will," "may" and similar words and
expressions. Each such statement is subject to
uncertainties, risks and other factors that could cause
actual results or performance to differ materially from the
results or performance expressed in or implied by such
statements. The forward-looking statements in this news
release that contain projections of the company's expected
financial performance and other projections regarding future
performance are inherently subject to change, given the
nature of projections, and the company's actual performance
may be better or worse than projected. Uncertainties, risks
and other factors that may cause actual results or
performance to differ materially from any results or
performance expressed or implied by forward-looking
statements in this news release include: (1) the company’s
ability to manage its operating expenses and realize
operating efficiencies, (2) the company’s ability to
maintain and grow its sales with existing and new customers,
(3) the company’s ability to retain existing members of its
senior management team and to attract additional management
employees, (4) the company’s ability to manage fluctuations
in the availability and cost of key materials and tools of
production, (5) general economic conditions that might
impact demand for the company’s products, (6) competition
from existing or new participants in the pet products
industry, (7) the company’s ability to design and bring to
market new products on a timely and profitable basis, (8)
challenges to the company’s patents or trademarks on
existing or new products, or (9) the company’s ability to
secure access to sufficient capital on favorable terms to
manage and grow its business. A discussion of other risk
factors that may cause actual results to differ from the
results expressed in or implied by these forward-looking
statements can be found in the company's periodic filings
with the SEC. The company disclaims any duty to provide
updates to the forward-looking statements and projections
made in this news release.
Contacts:
OurPet's Company
Dr. Steven Tsengas or John G. Murchie
440-354-6500 |